Enzoglaz Forte 180mg/96mg/200mg Tablet is a combination pharmaceutical formulation containing Bromelain 180mg, Trypsin 96mg, and Rutoside 200mg, designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits significant anti-inflammatory and analgesic properties by modulating the inflammatory response and promoting the breakdown of fibrin. Trypsin, a serine protease enzyme, complements this action by facilitating the degradation of damaged proteins and reducing edema through enhanced microcirculation. Rutoside, a bioflavonoid with antioxidant and venotonic activity, strengthens capillary walls, reduces capillary permeability, and improves microvascular blood flow, thereby aiding in the management of vascular fragility and inflammation. Enzoglaz Forte is indicated for the treatment of acute and chronic inflammatory conditions, including post-traumatic edema, phlebitis, thrombophlebitis, and other disorders characterized by inflammation and impaired microcirculation. The synergistic action of these components contributes to accelerated resolution of inflammation, reduction of pain and swelling, and improved tissue repair. This medication should be used under medical supervision, considering contraindications such as hypersensitivity to any of the components, bleeding disorders, or active peptic ulcers. Enzoglaz Forte provides an effective therapeutic option for managing inflammation and vascular-related conditions.